The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday: ** AstraZeneca Plc took a further step to bolster its pipeline of new cancer drugs by agreeing to acquire privately held U.S. biotech company Amplimmune for up to $500 million.** Dutch telecoms group KPN announced improved terms for the sale of its German business E-Plus to Spain's Telefonica, in a deal worth 8.55 billion euros ($11.46 billion) that now has the support of Carlos Slim's America Movil .
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN remained unchanged at $50.67. In the past year, the shares have traded as low as $44.17 and as high as $53.45. On average, 1772140 shares of AZN exchange hands on a given day and today's volume is recorded at 0.
Source
